$3.53
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 72 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Country

US

CEO

Mr. David Portnoy

IPO date

1994

Employees

72

ISIN

US2288951088

Key stats

Open

$3.68

Volume

5.64K

Market cap

$27.66M

Prev. close

$3.53

Impl / hst vl

-

Open interest

$0.00

$3.45

Day’s Range

$3.75

$2.72

52W Range

$4.14

Valuation

22
Valuation score
Overvalued
P/E
-
P/S
0.88
P/B
-
Current ratio
0.62
Debt / Equity
-
ROE
-
Gross margin
78.44%
Income growth
-101.23%
FCF growth
-

May

30

Dividends

The last payment date was May 30, 2025

Div. per Share

$0.15

Div. Yield

4.37%

Payout Ratio

-

Div. Growth YoY

-40.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 3 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$8.67
The top 3 analysts forecasts that 12-month price may increase by 145.61%, with a low of $8.59 and a high of $8.93
$8.59
Low
$8.67
Avg
$8.93
High
Current price

Earnings

Q1 ‘26 revenue
$7.68M
Q1 ‘26 net income
$47.10K
Revenue
Net income
Previous EPS
$0.01
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply